JPH0549672A - Trasnfusion container - Google Patents

Trasnfusion container

Info

Publication number
JPH0549672A
JPH0549672A JP3237097A JP23709791A JPH0549672A JP H0549672 A JPH0549672 A JP H0549672A JP 3237097 A JP3237097 A JP 3237097A JP 23709791 A JP23709791 A JP 23709791A JP H0549672 A JPH0549672 A JP H0549672A
Authority
JP
Japan
Prior art keywords
container
drug
liquid
bottle
infusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3237097A
Other languages
Japanese (ja)
Other versions
JP3238170B2 (en
Inventor
Teruhiro Yoshida
彰宏 吉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HISHIYAMA SEIYAKU KK
Original Assignee
HISHIYAMA SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HISHIYAMA SEIYAKU KK filed Critical HISHIYAMA SEIYAKU KK
Priority to JP23709791A priority Critical patent/JP3238170B2/en
Publication of JPH0549672A publication Critical patent/JPH0549672A/en
Application granted granted Critical
Publication of JP3238170B2 publication Critical patent/JP3238170B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PURPOSE:To facilitate a communication operation by providing hanging holes respectively on the sealing surfaces on the liquid housing container side and drug container side of a bag-shaped packaging material for aseptically sealing and housing a liquid housing container, communicating means and drug container. CONSTITUTION:The soln. in a bottle 1 falls by gravity and migrates into the drug container 2 and the drug in the drug container 2 is dissolved when the transfusion container is previously hung by hooking the 1st hanging hole 7 on the liquid housing container side to a hanger and the bottle 1 and the drug container 2 are communicated by the communicating means 3. The prepd. liquid drug falls and migrates by gravity into the bottle 1 when the transfusion container is hung by hooking the 2nd hanging hole 8 on the drug container 2 side to the hanger. The 1st sealing part 9 is disconnected from a perforated line 11 and a transfusion set is connected to the exposed liquid drug taking out port 12 of the bottle 1 in the stage when the liquid drum migrates completely into the bottle 1 in the case of execution of a transfusion treatment. The need for an operation to move the soln. and the liquid drum is eliminated in this way.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は点滴治療に用いられる輸
液容器に関し、詳しくは治療時に無菌的に薬液を調整し
て使用することができるようにした輸液容器に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an infusion container used for drip treatment, and more particularly to an infusion container which can be used by aseptically adjusting a drug solution during treatment.

【0002】[0002]

【従来の技術】液状で保存すると変質する抗生物質や抗
癌剤などの粉末あるいは凍結乾燥された薬剤は、一般に
バイアルなどに収容されており、点滴治療を行う際に溶
解液で溶解して使用される。従来このような粉末あるい
は凍結乾燥剤は、薬剤の入ったバイアルと溶解液の入っ
た容器とを両頭針または連結管などの連通用具を用いて
連通し、溶解液を薬剤の入った容器に移し、薬剤を溶解
液で溶解して薬液に調製している。ところがこの操作は
煩雑で手間がかかる上に、薬剤の入った容器に連通用の
孔をあける操作を行うので調整される薬液が汚染される
恐れがある。
2. Description of the Related Art Powders such as antibiotics and anticancer agents which are deteriorated when stored in liquid form or freeze-dried drugs are generally contained in vials and used by being dissolved in a solution when performing drip treatment. .. Conventionally, such powders or freeze-dried agents are communicated with a vial containing a drug and a container containing a solution using a communication tool such as a double-ended needle or a connecting pipe, and the solution is transferred to the container containing the drug. , A drug is dissolved in a solution to prepare a drug solution. However, this operation is complicated and time-consuming, and since the operation for making a communication hole in the container containing the drug is carried out, the drug solution to be prepared may be contaminated.

【0003】かかる問題を解決するものとして、特開平
2-1227号公報に薬剤容器と溶解液や希釈液(以下、総称
して「溶解液」という)の容器との連通が容易であり、
調製された薬液の汚染を確実に防止することができる輸
液容器が提案されている。この輸液容器は図6に示すよ
うに、内部に溶解液が収容された可撓性容器40と該可撓
性容器40に連結されたカプセル41と、該カプセル41内に
保持される薬剤容器42と、前記可撓性容器40の内部と薬
剤容器42の内部とを連通する連通手段43とからなってい
る。可撓性容器40は最上端に閉鎖膜44を備えた液体通路
部45を有しており、一方薬剤容器42の口部46は刺通可能
な栓で密封されている。前記連通手段43は中間にハブ47
を有し、両端に刃先を有する中空の穿刺針48と、該穿刺
針48の一方の刃によって薬剤容器42の栓が刺通された後
に、穿刺針48の他方の刃によって可撓性容器40の閉鎖膜
44が刺通されるように連通順序を制御する制動手段49と
からなっている。
As a means for solving such a problem, Japanese Patent Laid-Open No.
In the 2-1227 publication, it is easy to establish communication between a drug container and a solution or diluent (hereinafter collectively referred to as "solution") container,
There has been proposed an infusion container capable of reliably preventing contamination of a prepared drug solution. This infusion container is, as shown in FIG. 6, a flexible container 40 in which a solution is stored, a capsule 41 connected to the flexible container 40, and a drug container 42 held in the capsule 41. And a communication means 43 for communicating the inside of the flexible container 40 and the inside of the medicine container 42. The flexible container 40 has a liquid passage 45 with a closure membrane 44 at the uppermost end, while the mouth 46 of the drug container 42 is sealed with a pierceable stopper. The communication means 43 has a hub 47 in the middle.
And a hollow puncture needle 48 having blade edges at both ends, and after the stopper of the drug container 42 has been pierced by one blade of the puncture needle 48, the flexible container 40 by the other blade of the puncture needle 48. Closure membrane
The braking means 49 controls the communication sequence so that 44 is pierced.

【0004】前記制動手段49によって、薬剤容器42の栓
が刺通された後に可撓性容器40の閉鎖膜44が刺通され
る。この刺通操作には実施例として図7に示されるよう
なカム50を有するキャップ51をカプセル41に被せること
により、カム50が押さえ部材52のカムフォロア部53に当
接し、キャップ51の回転により押さえ部材52が下方に移
動するようになっている。その際、押さえ部材52のガイ
ド棒54とカプセル41の内面に形成されたガイド溝55の嵌
合によって薬剤容器42は回転不能かつ軸方向移動自在に
ガイドされ昇降するように構成されている。
By the braking means 49, the closure film 44 of the flexible container 40 is pierced after the stopper of the drug container 42 is pierced. For this piercing operation, by covering the capsule 41 with a cap 51 having a cam 50 as shown in FIG. 7 as an example, the cam 50 abuts the cam follower portion 53 of the pressing member 52 and is pressed by the rotation of the cap 51. The member 52 is adapted to move downward. At that time, the medicine container 42 is configured so as not to be rotatable but axially movable so as to move up and down by fitting the guide rod 54 of the pressing member 52 and the guide groove 55 formed on the inner surface of the capsule 41.

【0005】[0005]

【発明が解決しょうとする課題】しかしながら、かかる
輸液容器は内部薬剤の汚染防止および薬剤容器と溶解液
容器との連通の簡略化という点に関してはかなり改良さ
れたけれども、制動手段49の部品が複雑であるとともに
部品点数が多く、またキャップ51の回転操作により連通
を行わねばならず、かなりの手間を要すという問題があ
る。本発明の目的は連通操作がきわめて簡単で、かつ部
品点数の少ない輸液容器を提供することである。
However, although such an infusion container has been considerably improved in terms of prevention of contamination of the internal drug and simplification of communication between the drug container and the solution container, the parts of the braking means 49 are complicated. In addition, there is a problem that the number of parts is large and communication is required by rotating the cap 51, which requires a considerable amount of work. An object of the present invention is to provide an infusion container having a very simple communication operation and a small number of parts.

【0006】[0006]

【課題を解決するための手段】本発明は液体通路部と薬
液取出口を有し内部に溶解液または希釈液を収容した液
体収容容器と、内部に薬剤を収容した薬剤容器と、該液
体収容容器と薬剤容器を無菌的に連通させる連通手段、
および前記液体収容容器、連通手段、薬剤容器をこの順
序に配置して無菌的に密封し収容した袋状の包材からな
る輸液容器において、前記包材が、前記液体収容容器側
と薬剤容器側のシ−ル面にそれぞれ吊下げ用孔を有して
なる輸液容器である。また本発明は前記輸液容器におい
て、液体収容容器側のシ−ル面は薬液取出口の収容部分
が幅狭になるように形成され、かつ薬液取出口の収容部
分を横切るように切取線が設けられてなる輸液容器であ
る。
According to the present invention, there is provided a liquid container having a liquid passage portion and a drug solution outlet and containing a solution or a diluent therein, a drug container containing a drug therein, and the liquid container. Communication means for aseptically communicating the container and the drug container,
And an infusion container composed of a bag-shaped packaging material in which the liquid storage container, the communication means, and the drug container are arranged in this order and are aseptically sealed, and the packaging material is the liquid storage container side and the drug container side. Is a transfusion container having holes for hanging on the respective seal surfaces. Further, in the present invention, in the above-mentioned infusion container, the seal surface on the side of the liquid container is formed so that the accommodating portion of the drug solution outlet is narrow, and a cut line is provided so as to cross the accommodating portion of the drug solution outlet. It is an infusion container.

【0007】更に、本発明は前記輸液容器において、内
部に溶解液または希釈液が収容されており、一端に閉鎖
膜を備えた液体通路部を有し、他端に薬液取出口を有
し、かつ前記液体通路部の外周面に複数の環状リブと、
該環状リブにほぼ垂直の縦ガイドが設けられたボトル
と、第1円筒体と該第1円筒体の一端に形成された底壁
とからなる一端が開放されたほぼ円筒状の第1部材と、
第2円筒体と該第2円筒体の内部に形成された隔壁とか
らなる両端が開放されたほぼ円筒状の第2部材とからな
る連通部と、口部が刺通可能な栓で密封された薬剤容器
と、前記ボトル、連通部および薬剤容器を無菌的に密封
してなる包材とからなり、前記第1部材は中間にハブを
有し両端に刃先を有する中空の穿刺針を備え、かつ開放
側端部に前記ボトルの環状リブと係合する内方環状突起
を有しており、さらに前記第1円筒体には少なくとも1
つの切込みがその軸方向にほぼ平行に形成されるととも
に、少なくとも1つの外方突起がその外周面に形成され
ており、前記第2部材の隔壁には前記穿刺針の外径とほ
ぼ同一内径の開口部が形成されており、かつ前記ボトル
側の第2円筒体に前記第1部材の外方突起が嵌まる孔が
形成されてなる輸液容器である。
Further, the present invention provides the above-mentioned infusion container, in which a dissolving liquid or a diluting liquid is contained, a liquid passage portion having a closing film is provided at one end, and a chemical liquid outlet is provided at the other end. And a plurality of annular ribs on the outer peripheral surface of the liquid passage portion,
A bottle in which a substantially vertical guide is provided on the annular rib; and a substantially cylindrical first member having one open end including a first cylinder and a bottom wall formed at one end of the first cylinder. ,
A communication portion including a second cylindrical body and a partition member formed inside the second cylindrical body and having a substantially cylindrical second member having open both ends, and a mouth portion sealed with a pierceable plug. A drug container, and a packaging material obtained by aseptically sealing the bottle, the communication part and the drug container, wherein the first member includes a hollow puncture needle having a hub in the middle and blade edges at both ends, Further, it has an inner ring-shaped projection at the open side end portion that engages with the ring-shaped rib of the bottle, and further, at least 1 is formed on the first cylindrical body.
Two notches are formed substantially parallel to the axial direction, and at least one outer protrusion is formed on the outer peripheral surface thereof, and the partition wall of the second member has an inner diameter substantially the same as the outer diameter of the puncture needle. The infusion container has an opening formed therein, and a hole in which the outer projection of the first member fits is formed in the bottle-side second cylinder.

【0008】更にまた、本発明は前記輸液容器におい
て、第1部材の切込みが軸対称に一対形成されてなる輸
液容器である。また、本発明は前記輸液容器において、
第1部材の底壁に空気抜き孔が形成されてなる輸液容器
である。更に、本発明は前記輸液容器において、穿刺針
のボトル側刃先にゴムキャップが被せられてなる輸液容
器である。
Furthermore, the present invention is the above-mentioned infusion container, wherein a pair of cuts of the first member are formed axially symmetrically. Further, the present invention provides the infusion container,
The infusion container has an air vent hole formed in the bottom wall of the first member. Further, the present invention is the above-mentioned infusion container, wherein a rubber cap is put on the bottle-side cutting edge of the puncture needle.

【0009】[0009]

【作用】本発明の輸液容器においては、吊下げ用の孔を
液体収容容器側のシ−ル面と薬剤容器側のシ−ル面の両
方に設けてあるので、単に輸液容器をハンガ−などに吊
下げておくだけで薬剤を溶解することができる。すなわ
ち最初液体収容容器側の吊下孔をハンガ−に掛けて輸液
容器を吊るしておき、連通手段により液体収容容器と薬
剤容器とを連通すると、液体収容容器の溶解液が自然落
下して薬剤容器に移行し薬剤容器の薬剤が溶解される。
次に輸液容器を薬剤容器側の吊下孔をハンガ−に掛けて
吊るすと、調製された薬液が薬剤容器から液体収容容器
に自然落下により移行する。輸液治療を行う場合には、
薬液が全て液体収容容器に移行した段階で液体収容容器
の薬液取出口に輸液セットを接続すればよい。
In the infusion container of the present invention, since the hanging holes are provided on both the seal surface on the liquid container side and the seal surface on the drug container side, the infusion container is simply a hanger or the like. The drug can be dissolved simply by suspending it in. That is, when the infusion container is first hung by hanging the suspension hole on the side of the liquid container on the hanger and the liquid container and the drug container are communicated by the communication means, the solution in the liquid container naturally falls and the drug container. And the drug in the drug container is dissolved.
Next, when the infusion container is hung by hanging the suspension hole on the side of the drug container on a hanger, the prepared drug solution is transferred from the drug container to the liquid storage container by spontaneous fall. When performing fluid therapy,
The infusion set may be connected to the drug solution outlet of the liquid container when all the drug solution is transferred to the liquid container.

【0010】また、図2の輸液容器においては、単にボ
トルを薬剤容器の方に押すだけで、連通部の作用によっ
て薬剤容器の内部とボトルの内部の連通を行うことがで
きる。すなわち、ボトルを薬剤容器の方へ押すと、第1
部材は外方突起と切込みによって軸方向内側に変形して
いるので第2部材の内部を摺動する。その結果、最初に
薬剤容器の栓が穿刺針によって刺通される。この場合ボ
トルの液体通路部の環状リブと第1部材の内方環状突起
は係合状態にあり、第1部材が摺動している間に穿刺針
が誤ってボトルの閉鎖膜を刺通することはない。
Further, in the infusion container of FIG. 2, the inside of the medicine container and the inside of the bottle can be communicated by the action of the communicating portion by simply pushing the bottle toward the medicine container. That is, when pushing the bottle towards the drug container,
Since the member is deformed inward in the axial direction by the outer protrusion and the notch, it slides inside the second member. As a result, the stopper of the drug container is first pierced by the puncture needle. In this case, the annular rib of the liquid passage portion of the bottle and the inner annular protrusion of the first member are in engagement with each other, and the puncture needle erroneously pierces the closure membrane of the bottle while the first member is sliding. There is no such thing.

【0011】薬剤容器の栓を刺通した後に、更にボトル
を薬剤容器の方へ押すと、第1部材の底壁が第2部材の
隔壁に達し、第1部材の摺動は停止する。この時第1部
材の外方突起が第2部材の孔に嵌まり、第1部材は元の
形状に復帰してボトルの環状リブと第1部材の内方突起
の係合が解かれる。更に第1部材を押すと、ボトルは穿
刺針の方へ移動して穿刺針がボトルの閉鎖膜を刺通す
る。
When the bottle is further pushed toward the medicine container after the stopper of the medicine container is pierced, the bottom wall of the first member reaches the partition wall of the second member and the sliding of the first member is stopped. At this time, the outer protrusion of the first member fits into the hole of the second member, the first member returns to its original shape, and the annular rib of the bottle is disengaged from the inner protrusion of the first member. When the first member is further pushed, the bottle moves toward the puncture needle, and the puncture needle pierces the closure membrane of the bottle.

【0012】[0012]

【実施例】次に、本発明の一例を実施例に基づいて説明
する。図1は本発明の輸液容器の一実施例を示す平面図
であり、図2は包材を除く輸液容器の一部断面を含む平
面図であり、図3は図2に示す第1部材の一部破断斜視
図であり、図4は図2に示す第2部材の一部破断斜視図
であり、図5は本発明の包材を除く輸液容器の他の実施
例を示す平面図であり、図6は従来の輸液容器の要部断
面図であり、図7は図6に示す輸液容器の連通手段の一
部破断斜視図である。図中、1は液体収容容器(ボト
ル)、2は薬剤容器、3は連通手段、4は包材、5は第
1部材、6は第2部材、7は第1吊下孔、8は第2吊下
孔、9は第1シ−ル部、10は第2シ−ル部、12は薬液取
出口、13は液体通路部を示す。
EXAMPLES Next, an example of the present invention will be described based on examples. 1 is a plan view showing an embodiment of the infusion container of the present invention, FIG. 2 is a plan view including a partial cross section of the infusion container excluding the packaging material, and FIG. 3 is a view of the first member shown in FIG. FIG. 4 is a partially broken perspective view, FIG. 4 is a partially broken perspective view of the second member shown in FIG. 2, and FIG. 5 is a plan view showing another embodiment of the infusion container excluding the packaging material of the present invention. 6 is a cross-sectional view of a main part of a conventional infusion container, and FIG. 7 is a partially cutaway perspective view of the communication means of the infusion container shown in FIG. In the figure, 1 is a liquid container (bottle), 2 is a drug container, 3 is a communicating means, 4 is a packaging material, 5 is a first member, 6 is a second member, 7 is a first hanging hole, and 8 is a first hanging hole. 2 is a suspension hole, 9 is a first seal part, 10 is a second seal part, 12 is a chemical solution outlet, and 13 is a liquid passage part.

【0013】図1および図2に示すように、本発明輸液
容器は内部に溶解液を収容したボトル1と、内部に乾燥
薬剤を収容した薬剤容器2と、このボトル1と薬剤容器
2を無菌的に連通させる連通手段3、およびボトル1、
連通手段3、薬剤容器2をこの順序に配置して無菌的に
密封し収容した袋状の包材4からなる輸液容器であり、
包材4のボトル1側のシ−ル面である第1シ−ル部9
と、薬剤容器2側のシ−ル面である第2シ−ル部10に
は、夫々吊下げ用の孔として第1吊下孔7と第2吊下孔
8が設けられている。そして第1シ−ル部9におけるシ
−ル面はボトル1の薬液取出口12の収容部分が幅狭にな
るように形成されており、第1シ−ル部9の薬液取出口
12収容部分には、好ましくはこの部分を横切るように切
取線11が設けられている。
As shown in FIGS. 1 and 2, the infusion container of the present invention contains a bottle 1 containing a solution therein, a drug container 2 containing a dry drug therein, and the bottle 1 and the drug container 2 are sterile. A communication means 3 and a bottle 1 for communicating with each other,
An infusion container comprising a bag-shaped packaging material 4 in which the communication means 3 and the drug container 2 are arranged in this order and are aseptically sealed and stored.
The first seal portion 9 which is the seal surface on the bottle 1 side of the packaging material 4.
The second seal portion 10, which is the seal surface on the side of the drug container 2, is provided with a first suspension hole 7 and a second suspension hole 8 as suspension holes, respectively. The seal surface of the first seal portion 9 is formed so that the accommodation portion of the chemical liquid outlet 12 of the bottle 1 is narrow, and the chemical liquid outlet of the first seal portion 9 is formed.
The 12 receiving portion is preferably provided with a cutoff line 11 across the portion.

【0014】以下各構成要素について詳しく説明する。
ボトル1はポリ塩化ビニル、ポリオレフィン、ポリエス
テル、ポリアミドなどの可撓性に富む材料で形成された
容器であり、その連通手段3に接続される側の端部には
閉鎖膜(ボトル1内の溶解液を外部から遮断するための
薄膜。図示せず)を備えた液体通路部13が形成され、こ
の液体通路部13と反対側の端部には薬液取出口12が形成
されている。そして液体通路部13の外周面には複数の環
状リブ14からなる段差部15が形成されている。また、こ
の環状リブ14とほぼ垂直方向、すなわちボトル1の軸方
向には、後述する第1部材5の切込み24に挿入される縦
ガイド16が軸方向に平行に形成されている。なお、縦ガ
イド16の数は限定するものでないが通常1〜2個であ
る。
Each component will be described in detail below.
The bottle 1 is a container formed of a highly flexible material such as polyvinyl chloride, polyolefin, polyester, polyamide, etc., and has a closed membrane (dissolved in the bottle 1 at the end connected to the communication means 3). A liquid passage portion 13 having a thin film (not shown) for shutting off the liquid from the outside is formed, and a chemical liquid outlet 12 is formed at the end opposite to the liquid passage portion 13. A step portion 15 composed of a plurality of annular ribs 14 is formed on the outer peripheral surface of the liquid passage portion 13. Further, a vertical guide 16 to be inserted into a notch 24 of the first member 5 described later is formed in parallel to the axial direction in a direction substantially perpendicular to the annular rib 14, that is, in the axial direction of the bottle 1. Although the number of the vertical guides 16 is not limited, it is usually 1 to 2.

【0015】薬剤容器2はガラスまたはプラスチック製
であり、内部には固体状(粉末を含む)の薬剤が収容さ
れている。薬剤容器2の口部17は穿刺針21を刺通可能な
ゴム栓で密封されている。連通手段3はボトル1側の第
1部材5と薬液容器2側の第2部材6からなっており、
ボトル1を薬剤容器2の方に押した時に、第1部材5の
穿刺針21が先ず薬剤容器2の栓を刺通し、次いでボトル
1の閉鎖膜を刺通するようになっている。
The medicine container 2 is made of glass or plastic, and a solid medicine (including powder) is contained therein. The mouth 17 of the drug container 2 is sealed with a rubber stopper capable of piercing the puncture needle 21. The communication means 3 comprises a first member 5 on the bottle 1 side and a second member 6 on the chemical liquid container 2 side,
When the bottle 1 is pushed toward the medicine container 2, the puncture needle 21 of the first member 5 first pierces the stopper of the medicine container 2 and then the closure membrane of the bottle 1.

【0016】第1部材5は第1円筒体18と該第1円筒体
18の一端に形成された底壁19とからなり、ボトル1側が
開放されたほぼ円筒状の部材で、ポリオレフィン、ポリ
塩化ビニル、ポリエステル、ABS樹脂、ポリカ−ボネ
−トなどの可撓性樹脂で製造される。第1部材5は中間
にハブ20を有し両端に刃先を有する中空の穿刺針21を備
えている。なお、本実施例においては、ハブ20は底壁19
と一体に形成されており、底壁19の中心の孔に穿刺針21
の針管が挿入され固着されているが、前記ハブ20を底壁
19と別体に形成して、針管が固着されたハブ20を底壁19
の孔に挿入する構造とすることも可能である。穿刺針21
のボトル1側の刃先には、薬剤容器2内の薬剤が洩れる
のを防ぐためのゴムキャップ34が被せられているのが好
ましい。また、ハブ20のボトル1側端部には止水性を高
めるために、O−リング33を設けるようにしてもよい。
The first member 5 includes a first cylindrical body 18 and the first cylindrical body.
It is a substantially cylindrical member that is composed of a bottom wall 19 formed at one end of 18 and is open on the side of the bottle 1. It is made of a flexible resin such as polyolefin, polyvinyl chloride, polyester, ABS resin, or polycarbonate. Manufactured. The first member 5 is provided with a hollow puncture needle 21 having a hub 20 in the middle and cutting edges at both ends. In this embodiment, the hub 20 is the bottom wall 19
It is formed integrally with the puncture needle 21 in the hole at the center of the bottom wall 19.
The needle tube is inserted and fixed, but the hub 20 is
The hub 20 to which the needle tube is fixed is formed as a separate body from the bottom wall 19
It is also possible to adopt a structure in which it is inserted into the hole. Puncture needle 21
It is preferable that the blade edge of the bottle 1 is covered with a rubber cap 34 for preventing the medicine in the medicine container 2 from leaking. In addition, an O-ring 33 may be provided at the end of the hub 20 on the bottle 1 side in order to improve water blocking performance.

【0017】第1部材5の開放側端部には、前記ボトル
1の環状リブ9と係合する内方環状突起22が形成されて
いる。この内方環状突起22は、穿刺針21が薬剤容器2の
栓を刺通するより前にボトル1の閉鎖膜を刺通しないよ
うにするための工夫であり、本発明輸液容器の組立に際
して、第1部材5にボトル1の液体通路部13を挿入し易
くするために、図2に示すようなテ−パ−23を形成して
おくのが好ましい。第1円筒体18には、図3に示すよう
な切込み24が形成されている。この切込み24は第1部材
5の内方への変形を容易ならしめるとともに、液体通路
部13の縦ガイド16を切込み24に挿入した時のガイド溝の
役目を果たすものであり、開放端側がやや幅広の台形の
形に形成するのが好ましい。切込み24の数は特に限定さ
れないが、第1部材5の軸方向内側への変形をスム−ズ
に行わせるためには、軸対称に複数個、通常2〜3個形
成するのが好ましい。
An inner annular projection 22 that engages with the annular rib 9 of the bottle 1 is formed at the open end of the first member 5. The inner annular protrusion 22 is a device for preventing the puncture needle 21 from piercing the closing membrane of the bottle 1 before piercing the stopper of the drug container 2, and is used for assembling the infusion container of the present invention. In order to facilitate insertion of the liquid passage portion 13 of the bottle 1 into the one member 5, it is preferable to form a taper 23 as shown in FIG. A notch 24 as shown in FIG. 3 is formed in the first cylindrical body 18. This notch 24 facilitates the inward deformation of the first member 5, and also serves as a guide groove when the vertical guide 16 of the liquid passage portion 13 is inserted into the notch 24, and the open end side is slightly It is preferably formed in the shape of a wide trapezoid. The number of cuts 24 is not particularly limited, but in order to smoothly deform the first member 5 inward in the axial direction, it is preferable to form a plurality of cuts 24 in axial symmetry, usually 2 to 3.

【0018】第1円筒体18の外周面には、第1部材5の
底壁19が第2部材6の隔壁29に達した時に、第2円筒体
28の孔32に嵌まる位置および大きさの外方突起25が形成
されている。この外方突起25の形状は特に限定されない
が、第2円筒体28の内周面との摺動性を考慮すれば、図
3に示されるような半球状であるのが好ましい。外方突
起25の数は1つでも複数個でもよいが、第1部材5の第
2部材6内への挿入をスム−ズに行わしめるためには、
切込み24と同様に軸対称に複数個形成するのが好まし
い。また外方突起25と切込み24とを図3に示すように交
互に配置してもよい。第1円筒体18の下端外周面には、
好ましくは図3に示すような環状溝37が形成される。こ
の環状溝37は輸液を行う前に第2円筒体28の内周面に形
成された第1環状小リブ35と係合しており、輸液時には
第2環状小リブ36と係合して、夫々輸液前および輸液時
における第1部材5と第2部材6の抜けを防止する役割
を果たしている。なお、26は空気抜き孔であり、第1部
材5を第2部材6内に挿入する際に、図2において27で
示す部分の空気が圧縮されて、その抵抗で連通操作に力
を要すようになるのを防止している。空気抜き孔26は通
常第1部材5の底壁19に形成される。
On the outer peripheral surface of the first cylindrical body 18, when the bottom wall 19 of the first member 5 reaches the partition wall 29 of the second member 6, the second cylindrical body 18 is formed.
An outer protrusion 25 is formed in a position and size that fits into the hole 32 of 28. The shape of the outer protrusion 25 is not particularly limited, but considering the slidability with the inner peripheral surface of the second cylindrical body 28, it is preferably a hemispherical shape as shown in FIG. The number of the outer protrusions 25 may be one or more, but in order to smoothly insert the first member 5 into the second member 6,
Similar to the cut 24, it is preferable to form a plurality of pieces in axial symmetry. Further, the outer protrusions 25 and the notches 24 may be alternately arranged as shown in FIG. On the outer peripheral surface of the lower end of the first cylindrical body 18,
Preferably, an annular groove 37 as shown in FIG. 3 is formed. The annular groove 37 engages with the first annular small rib 35 formed on the inner peripheral surface of the second cylindrical body 28 before the infusion, and engages with the second annular small rib 36 during the infusion. It plays a role of preventing the first member 5 and the second member 6 from coming off before and during infusion, respectively. Reference numeral 26 denotes an air vent hole, so that when the first member 5 is inserted into the second member 6, the air in the portion indicated by 27 in FIG. 2 is compressed, and the resistance thereof requires a force for the communication operation. Is being prevented. The air vent hole 26 is usually formed in the bottom wall 19 of the first member 5.

【0019】第2部材6は第2円筒体28と該第2円筒体
28の内部に形成された隔壁29とから構成されており、両
端が開放された構造になっている。第2部材6は第1部
材5と同様の材料で製造されており、前記隔壁29には穿
刺針21の外径とほぼ同一の内径を有する開口部30が形成
されている。穿刺針21はこの開口部30内を摺動しつつ移
動し、すなわち実質的な液密状態を保ちつつ移動しうる
ように構成されている。本実施例の第2円筒体28はバイ
アル2側が小径でボトル1側が大径であるが、必ずしも
これに限定されるものではなく、接続される口部17また
は液体通路部13のサイズに応じて適宜の直径を選定する
ことができる。薬剤容器2が接続される側の第2円筒体
28内部には肩部31が形成されており、薬剤容器2の口部
17の上端外周部がこの肩部31に当接している。また、隔
壁29よりもボトル1側の第2円筒体28には前記外方突起
25の嵌まる孔32が外方突起25と同数形成されている。
The second member 6 includes a second cylindrical body 28 and the second cylindrical body.
It is composed of a partition 29 formed inside 28, and has a structure in which both ends are open. The second member 6 is made of the same material as the first member 5, and the partition wall 29 is formed with an opening 30 having an inner diameter substantially the same as the outer diameter of the puncture needle 21. The puncture needle 21 is configured to move while sliding within the opening 30, that is, to move while maintaining a substantially liquid-tight state. The second cylindrical body 28 of the present embodiment has a small diameter on the side of the vial 2 and a large diameter on the side of the bottle 1, but it is not necessarily limited to this, depending on the size of the mouth portion 17 or the liquid passage portion 13 to be connected. An appropriate diameter can be selected. Second cylindrical body on the side to which the drug container 2 is connected
A shoulder portion 31 is formed inside 28, and the mouth portion of the drug container 2 is formed.
The outer peripheral portion of the upper end of 17 is in contact with this shoulder portion 31. Further, the second protrusion 28 on the bottle 1 side of the partition 29 has the outward projection.
The holes 32 into which 25 are fitted are formed in the same number as the outer protrusions 25.

【0020】35および36はそれぞれ第2円筒体28の内周
面に形成された第1の環状小リブおよび第2の環状小リ
ブであり、これら2つの環状小リブは前述の環状溝37と
係合する。第1の環状小リブ35は環状溝37と係合して
(図2参照)本発明の輸液容器をセッティングする際の
位置決めの役割を果たすとともに、第1部材5と第2部
材6の抜け防止の役割も果たしている。また、連通が終
了して輸液を行う場合には、第2環状小リブ36と環状溝
37とが係合して、第1部材5と第2部材6が移動して抜
けてしまうのを防ぐ役割を果たしている。
Reference numerals 35 and 36 respectively denote a first annular small rib and a second annular small rib formed on the inner peripheral surface of the second cylindrical body 28, and these two annular small ribs are the same as the aforementioned annular groove 37. Engage. The first annular small rib 35 engages with the annular groove 37 (see FIG. 2), plays a role of positioning when setting the infusion container of the present invention, and prevents the first member 5 and the second member 6 from coming off. Also plays a role. Further, when the communication is completed and the infusion is performed, the second annular small rib 36 and the annular groove are
37 and 37 are engaged with each other to prevent the first member 5 and the second member 6 from moving and coming off.

【0021】包材4はボトル1、薬剤容器2および連通
手段3を無菌的に密封する外装材であり、ポリオレフィ
ン、ポリエステル、ポリアミド、ポリ塩化ビニル、ポリ
塩化ビニリデンなどで形成される。そして包材4のボト
ル1側の端部および薬剤容器2側の端部は熱溶着などの
手段によって密封されており、ボトル1側の接着面であ
る第1シール部9と薬剤容器2側の接着面である第2シ
ール部10には夫々ハンガーなどに掛けて吊下げるための
第1吊下孔7および第2吊下孔8が穿設されている。第
1シール部9におけるシール面はボトル1の薬液取出口
12の収容部分が幅狭になるように形成されており、第1
シール部9の薬液取出口12の収容部分には、好ましくは
この幅狭部分を横切るように切取線11が設けられてい
る。
The packaging material 4 is an exterior material for aseptically sealing the bottle 1, the drug container 2 and the communication means 3, and is formed of polyolefin, polyester, polyamide, polyvinyl chloride, polyvinylidene chloride or the like. The end of the packaging material 4 on the bottle 1 side and the end of the packaging container 4 on the side of the drug container 2 are sealed by means such as heat welding, and the first seal portion 9 that is the adhesive surface on the bottle 1 side and the drug container 2 side. The second seal portion 10, which is an adhesive surface, is provided with a first hanging hole 7 and a second hanging hole 8 for hanging on a hanger or the like. The sealing surface of the first sealing portion 9 is the chemical solution outlet of the bottle 1.
The 12 accommodating portions are formed so as to have a narrow width.
A cutoff line 11 is preferably provided in a portion of the seal portion 9 in which the liquid medicine outlet 12 is accommodated so as to cross the narrow portion.

【0022】本発明の輸液容器は、ボトル1、薬剤容器
2および連通手段3を、クリ−ンル−ムなどの無菌的雰
囲気下で図2に示される状態にセットしたのち、包材4
に収容してその開口部分をシールし、第1吊下孔7およ
び第2吊下孔8を穿設した後必要ならば切取線11を設け
ることにより得られる。本発明において、薬剤容器2に
収容される薬剤の例としては次のようなものがある。抗
生物質としては、セファゾリンナトリウム、セフチゾキ
シムナトリウム、塩酸セフォチアム、塩酸セフメノキシ
ム、セファセトリルナトリウム、セファマンドールナト
リウム、セファロリジン、セフォタキシムナトリウム、
セフォテタンナトリウム、セフォペラゾンナトリウム、
セフスロジンナトリウム、セフテゾールナトリウム、セ
フピラミドナトリウム、セフメタゾールナトリウム、セ
フロキシムナトリウムなどのセフェム系抗生物質、ま
た、アンピシリンナトリウム、カルベニシリンナトリウ
ム、スルベニシリンナトリウム、チカルシリンナトリウ
ムなどのペニシリン系抗生物質などがある。抗腫瘍剤と
しては、マイトマイシンC、フルオロウラシル、テフガ
ール、シタラビンなどがある。抗潰瘍剤としては、ファ
モチジン、塩酸ラニチジン、シメチジンなどがある。ま
た、ボトル1に収容される溶解液としては、たとえば生
理食塩水、5%ブドウ糖液、注射用蒸留水のほか、各種
の電解質を含む溶液が用いられる。
In the infusion solution container of the present invention, the bottle 1, the drug container 2 and the communication means 3 are set in the state shown in FIG. 2 under a sterile atmosphere such as a clean room, and then the packaging material 4 is used.
It is obtained by sealing the opening portion by housing the first suspension hole 7 and the second suspension hole 8 and then providing a cutoff line 11 if necessary. In the present invention, examples of the medicine contained in the medicine container 2 are as follows. Antibiotics include cefazolin sodium, ceftizoxime sodium, cefotiam hydrochloride, cefmenoxime hydrochloride, cefacetril sodium, cefamandole sodium, cephaloridine, cefotaxime sodium,
Cefotetan sodium, cefoperazone sodium,
Cephem antibiotics such as cefsulodin sodium, ceftezol sodium, cefpyramide sodium, cefmetazole sodium, cefuroxime sodium, and penicillin antibiotics such as ampicillin sodium, carbenicillin sodium, sulbenicillin sodium and ticarcillin sodium. There are substances, etc. Antitumor agents include mitomycin C, fluorouracil, Tefgar, cytarabine and the like. Antiulcer agents include famotidine, ranitidine hydrochloride, cimetidine and the like. In addition, as the solution to be stored in the bottle 1, for example, physiological saline, 5% glucose solution, distilled water for injection, and solutions containing various electrolytes are used.

【0023】次に図1〜図4の輸液容器の連通操作につ
いて説明する。連通操作を開始する前には、第1部材5
の内方環状突起22とボトル1の環状リブ14とがボトル1
先端から数えて最初の溝の部分で係合しており、この状
態では第1部材5は外方突起25および切込み24の作用に
より内方に変形している。ボトル1をバイアル2側へ押
していくと、ボトル1は内方環状突起22と係合している
ので、ボトル1と穿刺針21の位置関係に変化はなく、第
1部材5が第2部材6内を摺動していく。従って穿刺針
21も移動して、まず薬剤容器2のゴム栓が刺通される。
このゴム栓の刺通が完了して第1部材5の底壁19が第2
部材6の隔壁29まで到達すると、外方突起25は孔32内に
嵌まるので、第1部材5の内方への変形は部材自身の弾
性力によって元の形状に戻る。その結果、内方環状突起
22と環状リブ14との係合状態が解かれる(移動可能な程
度に緩くなる状態を含む)。そして、薬剤容器2方向に
さらにボトル1を押すと、ボトル1が第1部材5内に挿
入されて、今度は穿刺針21によって閉鎖膜が刺通され
る。連通が完了したのち第1吊下孔7をハンガーに掛け
て輸液容器を吊るすと、ボトル1の溶解液が自然落下し
て薬剤容器2に移行し、薬剤容器2内の薬剤が溶解され
る。次に第2吊下孔8をハンガーに掛けて輸液容器を吊
るすと、調製された薬液が薬剤容器2からボトル1に自
然落下により移行する。輸液治療を行う場合には、薬液
が全てボトル1に移行した段階で切取線11から下の第1
シール部9を切離し、露出されたボトル1の薬液取出口
12に輸液セットを接続すればよい。
Next, the operation of communicating the infusion container shown in FIGS. 1 to 4 will be described. Before starting the communication operation, the first member 5
The inner annular protrusion 22 of the bottle and the annular rib 14 of the bottle 1
The first groove 5 is engaged at the first groove portion counted from the tip, and in this state, the first member 5 is deformed inward by the action of the outer protrusion 25 and the notch 24. When the bottle 1 is pushed toward the vial 2 side, the bottle 1 is engaged with the inner annular protrusion 22, so that the positional relationship between the bottle 1 and the puncture needle 21 does not change, and the first member 5 is replaced by the second member 6 Sliding inside. Therefore puncture needle
21 also moves, and the rubber stopper of the medicine container 2 is pierced first.
When the rubber plug is completely pierced, the bottom wall 19 of the first member 5 becomes the second wall.
When reaching the partition wall 29 of the member 6, the outer protrusion 25 fits into the hole 32, so that the inward deformation of the first member 5 returns to its original shape by the elastic force of the member itself. As a result, the inner annular protrusion
The engagement state between 22 and the annular rib 14 is released (including a state where the annular rib 14 becomes loose enough to move). Then, when the bottle 1 is further pushed toward the medicine container 2, the bottle 1 is inserted into the first member 5, and the puncture needle 21 pierces the closure film this time. When the first suspension hole 7 is hung on the hanger and the infusion container is suspended after the communication is completed, the solution in the bottle 1 spontaneously drops and moves to the drug container 2, and the drug in the drug container 2 is dissolved. Next, the second suspension hole 8 is hung on a hanger to suspend the infusion solution container, and the prepared drug solution is transferred from the drug container 2 to the bottle 1 by spontaneous fall. When performing infusion therapy, when the drug solution is completely transferred to the bottle 1, the first line below the cut line 11
The seal 9 is cut off to expose the exposed chemical solution of the bottle 1.
Connect the infusion set to 12.

【0024】図5は本発明の包材を除く輸液容器の他の
実施例を示す概略平面図である。図5の輸液容器は、薬
剤が収容された薬剤容器61を収納するカプセル65、溶解
液が収容され、かつ放出出口64を有する溶解液容器62、
前記薬剤容器61を前記溶解液容器62へ向かってカプセル
65内を移動させるための押圧手段66、前記薬剤容器61と
前記溶解液容器62は導管手段63で連結され、両容器61と
62とを選択的に連通する破断部材67および中空針68とか
らなっている。図5の輸液容器の連通操作は、先ず押圧
手段66で薬剤容器61をカプセル65内で下方へ移行させる
ことによって、中空針68の先端が薬剤容器の端部のゴム
栓69を刺通する。次いで、人手によって破断部材67を折
り通路を開くことによって、溶解液容器62と薬剤容器61
が連通される。そして溶解液容器62の溶解液が薬剤容器
に入り薬剤と混合する。その後、薬剤を混合した混合液
は溶解液容器62へ移行され、放出出口64から点滴され
る。
FIG. 5 is a schematic plan view showing another embodiment of the infusion container excluding the packaging material of the present invention. The infusion container of FIG. 5 includes a capsule 65 for containing a drug container 61 containing a drug, a solution container 62 for containing a solution and a discharge outlet 64,
Capsule the drug container 61 toward the solution container 62
Pressing means 66 for moving the inside of 65, the drug container 61 and the dissolution liquid container 62 are connected by a conduit means 63, and both containers 61
It comprises a breaking member 67 and a hollow needle 68 that selectively communicate with 62. In the communication operation of the infusion container of FIG. 5, first, the drug container 61 is moved downward in the capsule 65 by the pressing means 66, so that the tip of the hollow needle 68 pierces the rubber stopper 69 at the end of the drug container. Next, the breaking member 67 is manually folded and the passage is opened, whereby the dissolution liquid container 62 and the drug container 61 are
Are communicated. Then, the dissolution liquid in the dissolution liquid container 62 enters the medicine container and is mixed with the medicine. After that, the mixed liquid in which the drug is mixed is transferred to the dissolution liquid container 62, and is drip-dried from the discharge outlet 64.

【0025】[0025]

【発明の効果】以上説明してきたことから明らかなよう
に、本発明の輸液容器は包材の液体収容容器側およびバ
イアル側のシール面に輸液容器吊り下げ用の孔が設けら
れているので、溶解液および薬液を移動させる操作(溶
解液容器を押したり揉んだりする操作)が不要になる。
また図2の輸液容器は「押す」操作だけで連通操作を行
ううことができ、従来の回転操作式の輸液容器に比べて
簡単な動作で薬剤と溶解液の混合を行うことができる。
更に、連通操作が単純化されたことに伴い、容器全体の
部品点数が少なくなり、かつ構造も簡単にすることがで
きるので、製品のコストダウンを計ることができる。
As is apparent from what has been described above, the infusion container of the present invention is provided with holes for suspending the infusion container on the sealing surfaces of the packaging material on the liquid container side and the vial side. The operation of moving the dissolution liquid and the chemical liquid (operation of pushing or rubbing the dissolution liquid container) becomes unnecessary.
In addition, the infusion container of FIG. 2 can be communicated by simply “pushing” it, and the drug and the solution can be mixed with a simple operation as compared with the conventional rotary operation type infusion container.
Further, since the communication operation is simplified, the number of parts of the entire container can be reduced and the structure can be simplified, so that the cost of the product can be reduced.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の輸液容器の一実施例を示す平面図であ
る。
FIG. 1 is a plan view showing an embodiment of an infusion container of the present invention.

【図2】包材を除く輸液容器の一部断面を含む平面図で
ある。
FIG. 2 is a plan view including a partial cross section of the infusion container excluding the packaging material.

【図3】図2に示す第1部材の一部破断斜視図である。FIG. 3 is a partially cutaway perspective view of the first member shown in FIG.

【図4】図2に示す第2部材の一部破断斜視図である。4 is a partially cutaway perspective view of a second member shown in FIG.

【図5】本発明の包材を除く輸液容器の他の実施例を示
す平面図である。
FIG. 5 is a plan view showing another embodiment of the infusion container excluding the packaging material of the present invention.

【図6】従来の輸液容器の要部断面図である。FIG. 6 is a sectional view of a main part of a conventional infusion container.

【図7】図6に示す輸液容器の連通手段の一部破断斜視
図である。
7 is a partially cutaway perspective view of the communication means of the infusion solution container shown in FIG.

【符号の説明】[Explanation of symbols]

1 液体収容容器(ボトル) 2 薬剤容器 3 連通手段 4 包材 5 第1部材 6 第2部材 7 第1吊下孔 8 第2吊下孔 9 第1シ−ル部 10 第2シ−ル部 12 薬液取出口 13 液体通路部 DESCRIPTION OF SYMBOLS 1 Liquid storage container (bottle) 2 Chemical | medical agent container 3 Communication means 4 Packaging material 5 1st member 6 2nd member 7 1st hanging hole 8 2nd hanging hole 9 1st seal part 10 2nd seal part 12 Chemical outlet 13 Liquid passage

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 液体通路部と薬液取出口を有し内部に溶
解液または希釈液を収容した液体収容容器と、内部に薬
剤を収容した薬剤容器と、該液体収容容器と薬剤容器を
無菌的に連通させる連通手段、および前記液体収容容
器、連通手段、薬剤容器をこの順序に配置して無菌的に
密封し収容した袋状の包材からなる輸液容器において、
前記包材が、前記液体収容容器側と薬剤容器側のシ−ル
面にそれぞれ吊下げ用孔を有してなる輸液容器。
1. A liquid container having a liquid passage portion and a drug solution outlet and containing a dissolving liquid or a diluent therein, a drug container containing a drug therein, and the liquid container and the drug container are aseptic. In the infusion container consisting of a bag-like packaging material in which the communication means for communicating with the liquid storage container, the liquid storage container, the communication means, and the drug container are placed in this order and are aseptically sealed and stored,
An infusion container, wherein the packaging material has hanging holes on the seal surfaces of the liquid container side and the drug container side, respectively.
【請求項2】 液体収容容器側のシ−ル面は薬液取出口
の収容部分が幅狭になるように形成され、かつ薬液取出
口の収容部分を横切るように切取線が設けられてなる請
求項1記載の輸液容器。
2. The seal surface on the liquid container side is formed so that the accommodating portion of the drug solution outlet is narrow, and a perforation line is provided so as to cross the accommodating portion of the drug solution outlet. The infusion container according to 1.
【請求項3】 内部に溶解液または希釈液が収容されて
おり、一端に閉鎖膜を備えた液体通路部を有し、他端に
薬液取出口を有し、かつ前記液体通路部の外周面に複数
の環状リブと、該環状リブにほぼ垂直の縦ガイドが設け
られたボトルと、 第1円筒体と該第1円筒体の一端に形成された底壁とか
らなる一端が開放されたほぼ円筒状の第1部材と、第2
円筒体と該第2円筒体の内部に形成された隔壁とからな
る両端が開放されたほぼ円筒状の第2部材とからなる連
通部と、 口部が刺通可能な栓で密封された薬剤容器と、 前記ボトル、連通部および薬剤容器を無菌的に密封して
なる包材とからなり、前記第1部材は中間にハブを有し
両端に刃先を有する中空の穿刺針を備え、かつ開放側端
部に前記ボトルの環状リブと係合する内方環状突起を有
しており、さらに前記第1円筒体には少なくとも1つの
切込みがその軸方向にほぼ平行に形成されるとともに、
少なくとも1つの外方突起がその外周面に形成されてお
り、前記第2部材の隔壁には前記穿刺針の外径とほぼ同
一内径の開口部が形成されており、かつ前記ボトル側の
第2円筒体に前記第1部材の外方突起が嵌まる孔が形成
されてなる請求項1または2記載の輸液容器。
3. A liquid or a diluting liquid is contained inside, a liquid passage portion having a closing film is provided at one end, and a chemical liquid outlet is provided at the other end, and an outer peripheral surface of the liquid passage portion. A plurality of annular ribs, a bottle provided with a vertical guide that is substantially vertical to the annular ribs, and one end formed of a first cylindrical body and a bottom wall formed at one end of the first cylindrical body is substantially open. A cylindrical first member, and a second
A drug having a communication part composed of a cylindrical body and a partition formed inside the second cylindrical body and having a substantially cylindrical second member with open ends, and a mouth portion sealed with a pierceable stopper. A container and a packaging material obtained by aseptically sealing the bottle, the communication part and the drug container, wherein the first member is provided with a hollow puncture needle having a hub in the middle and cutting edges at both ends, and is open. The side end portion has an inner annular projection that engages with the annular rib of the bottle, and further, at least one notch is formed in the first cylindrical body substantially parallel to its axial direction, and
At least one outer protrusion is formed on the outer peripheral surface of the second member, an opening having an inner diameter substantially the same as the outer diameter of the puncture needle is formed in the partition wall of the second member, and the second portion on the bottle side is formed. The infusion container according to claim 1 or 2, wherein a hole into which the outer protrusion of the first member is fitted is formed in the cylindrical body.
【請求項4】 第1部材の切込みが軸対称に一対形成さ
れてなる請求項3記載の輸液容器。
4. The infusion container according to claim 3, wherein a pair of cuts of the first member are formed axially symmetrically.
【請求項5】 第1部材の底壁に空気抜き孔が形成され
てなる請求項3記載の輸液容器。
5. The infusion container according to claim 3, wherein an air vent hole is formed in the bottom wall of the first member.
【請求項6】 穿刺針のボトル側刃先にゴムキャップが
被せられてなる請求項3記載の輸液容器。
6. The infusion container according to claim 3, wherein the blade edge of the puncture needle on the bottle side is covered with a rubber cap.
JP23709791A 1991-08-23 1991-08-23 Infusion container Expired - Fee Related JP3238170B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23709791A JP3238170B2 (en) 1991-08-23 1991-08-23 Infusion container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23709791A JP3238170B2 (en) 1991-08-23 1991-08-23 Infusion container

Publications (2)

Publication Number Publication Date
JPH0549672A true JPH0549672A (en) 1993-03-02
JP3238170B2 JP3238170B2 (en) 2001-12-10

Family

ID=17010371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23709791A Expired - Fee Related JP3238170B2 (en) 1991-08-23 1991-08-23 Infusion container

Country Status (1)

Country Link
JP (1) JP3238170B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0810312A (en) * 1994-04-28 1996-01-16 Otsuka Pharmaceut Factory Inc Infusion container
CN114081830A (en) * 2021-10-27 2022-02-25 浙江大学 Liquid production line is joined in marriage to hospital
EP4124330A1 (en) * 2021-07-26 2023-02-01 Kairish Innotech Private Ltd. Component mixing apparatus and system including a cannula for fluid transfer

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0810312A (en) * 1994-04-28 1996-01-16 Otsuka Pharmaceut Factory Inc Infusion container
EP4124330A1 (en) * 2021-07-26 2023-02-01 Kairish Innotech Private Ltd. Component mixing apparatus and system including a cannula for fluid transfer
DE212022000138U1 (en) 2021-07-26 2023-12-13 KAIRISH INNOTECH Private Ltd. Device and system for reconstituting a drug by liquid transfer
CN114081830A (en) * 2021-10-27 2022-02-25 浙江大学 Liquid production line is joined in marriage to hospital

Also Published As

Publication number Publication date
JP3238170B2 (en) 2001-12-10

Similar Documents

Publication Publication Date Title
US5308347A (en) Transfusion device
EP0843992A1 (en) Container for infusion
US7404814B2 (en) Infusion vessel
JPH0572830B2 (en)
JPH05317383A (en) Solution container equipped with means for communicating with chemical container
JPH06239352A (en) Solution injection set
US5261902A (en) Fluid container assembly
JP3565609B2 (en) Lysis solution injection set
JP3514505B2 (en) Manufacturing method of solution container
JP3238170B2 (en) Infusion container
JP2551318B2 (en) Infusion container
JPH08238300A (en) Infusion container
EP0809994B1 (en) Transfusion container
JP3345860B2 (en) Infusion container
JP3404177B2 (en) Infusion container
JP3478320B2 (en) Drug container with communication means
JPH07171192A (en) Infusion vessel
JP3175127B2 (en) Infusion container
JPH07184979A (en) Vessel for infusion
JPH04253863A (en) Transfusion container
JP4095851B2 (en) Infusion container and drug container
JP2550858B2 (en) Infusion container
JPH0542833Y2 (en)
JPH0542832Y2 (en)
JPH05192376A (en) Transfusing device

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081005

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081005

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091005

Year of fee payment: 8

LAPS Cancellation because of no payment of annual fees